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Abstract
Background: The Gram-positive bacterium Enterococcus faecium is a commensal of the human gastrointestinal
tract and a frequent cause of bloodstream infections in hospitalized patients. The mechanisms by which E. faecium
can survive and grow in blood during an infection have not yet been characterized. Here, we identify genes that
contribute to growth of E. faecium in human serum through transcriptome profiling (RNA-seq) and a high-
throughput transposon mutant library sequencing approach (Tn-seq).
Results: We first sequenced the genome of E. faecium E745, a vancomycin-resistant clinical isolate, using a
combination of short- and long read sequencing, revealing a 2,765,010 nt chromosome and 6 plasmids, with
sizes ranging between 9.3 kbp and 223.7 kbp. We then compared the transcriptome of E. faecium E745 during
exponential growth in rich medium and in human serum by RNA-seq. This analysis revealed that 27.8% of genes
on the E. faecium E745 genome were differentially expressed in these two conditions. A gene cluster with a role
in purine biosynthesis was among the most upregulated genes in E. faecium E745 upon growth in serum. The E.
faecium E745 transposon mutant library was then used to identify genes that were specifically required for growth
of E. faecium in serum. Genes involved in de novo nucleotide biosynthesis (including pyrK_2, pyrF, purD, purH) and
a gene encoding a phosphotransferase system subunit (manY_2) were thus identified to be contributing to E.
faecium growth in human serum. Transposon mutants in pyrK_2, pyrF, purD, purH and manY_2 were isolated from
the library and their impaired growth in human serum was confirmed. In addition, the pyrK_2 and manY_2 mutants
were tested for their virulence in an intravenous zebrafish infection model and exhibited significantly attenuated
virulence compared to E. faecium E745.
Conclusions: Genes involved in carbohydrate metabolism and nucleotide biosynthesis of E. faecium are essential
for growth in human serum and contribute to the pathogenesis of this organism. These genes may serve as targets
for the development of novel anti-infectives for the treatment of E. faecium bloodstream infections.
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Background
Enterococci are commensals of the gastrointestinal tract
of humans and animals, but some enterococcal species,
particularly E. faecium and E. faecalis, are also common
causes of hospital-acquired infections in immunocom-
promised patients [1]. While E. faecalis has been recog-
nized as an important nosocomial pathogen for over a
century, E. faecium has emerged as a prominent cause of
hospital-acquired infections over the last two decades
[2]. Since the 1980s, E. faecium acquired resistance to
multiple antibiotics, including β-lactams, aminoglyco-
sides and finally, to the glycopeptide vancomycin [3].
Nosocomial infections are almost exclusively caused by a
specific sub-population of E. faecium, termed clade A-1,
which has emerged from a background of human com-
mensal and animal E. faecium strains [4]. Strains in clade
A-1 carry genetic elements that are absent from animal
or human commensal isolates and which contribute to
gut colonization or pathogenicity [5–9]. Clade A-1 E.
faecium strains are rarely found in healthy individuals
but can colonize the gut of immunosuppressed, hospital-
ized patients to high-levels. These strains can then cause
infections by direct translocation from the gut into the
bloodstream [10–12]. In addition, due to faecal contam-
ination of the skin in hospitalized patients, the use of
intravenous catheters is another risk factor for the intro-
duction of E. faecium into the bloodstream [3, 13, 14].
Currently, E. faecium causes approximately 40% of
enterococcal bacteremias. Due to the accumulation of
antibiotic resistance determinants in clade A-1 strains,
E. faecium infections are more difficult to treat than
infections caused by E. faecalis or other enterococci
[15–17]. To cause bloodstream infections, E. faecium
needs to be able to survive and multiply in blood, but
the mechanisms by which it can do so, have not yet been
studied. To thrive in the bloodstream, an opportunistic
pathogen has to evade host immune mechanisms and to
adjust its metabolism to an environment that is relatively
poor in nutrients [18].
To identify genes that are conditionally essential in bac-
teria, high-throughput screening methods for transposon
mutant libraries have been developed and optimized for
many different bacterial species [19, 20]. To perform high-
throughput functional genomics in ampicillin-resistant,
vancomycin-susceptible clinical E. faecium strains, we pre-
viously developed a microarray-based transposon muta-
genesis screening method which was used to identify
genes involved in the development of endocarditis [7], re-
sistance to ampicillin [21], bile [22] and disinfectants [23].
However, microarray-based methods for transposon mu-
tant library screening are limited in their accuracy and can
only be used in strains for which the microarray was
designed. To address these limitations, several methods,
including Tn-seq [24] and TraDIS [25], which are based
on high-throughput sequencing of the junctions of the
transposon insertion sites and genomic DNA, have been
developed [26].
In this study, we set-up Tn-seq in the clinical E.
faecium isolate E745 to identify genes that contribute to
survival and growth in human serum. In addition, we
determined the transcriptional response of E. faecium
E745 in that same environment. Finally, we substantiated
the role of two E. faecium genes that contribute to
growth in serum and in virulence, in a zebrafish model
of infection. Collectively, our findings show that meta-
bolic adaptations are key to E. faecium growth in serum
and contribute to virulence.
Results
The complete genome sequence of E. faecium E745
In this study, we implemented RNA-seq and Tn-seq
analyses in E. faecium strain E745, an ampicillin- and
vancomycin-resistant clinical isolate. E. faecium E745
was isolated from a rectal swab of a hospitalized patient
as part of routine surveillance during an outbreak of
VRE in the nephrology ward of a Dutch hospital in
2000 [27, 28]. To allow the application of RNA-seq and
Tn-seq in E. faecium E745, we first determined the
complete genome sequence of this strain through a
combination of short-read Illumina sequencing and
long-read sequencing on the RSII Pacific Biosciences
and Oxford NanoPore’s MinION systems. This resulted
in a closed chromosomal sequence of 2,765,010 nt and
6 complete plasmids sequences, with sizes ranging be-
tween 9.3 kbp and 223.7 kbp (Additional file 1). Taken
together, the chromosome and plasmids have 3095 pre-
dicted coding sequences. Phylogenetic analysis of the
core genome of E745 and a set of 72 genomes repre-
senting global E. faecium diversity [4], showed that E.
faecium E745 is a clade A-1 strain (Fig. 1). The E745
chromosome contains a pathogenicity island with the
esp gene, which encodes a 207-kDa surface protein that
is involved in biofilm formation and infection [6, 29,
30]. The vancomycin resistance genes of E. faecium
E745 are of the vanA type [31] and are carried on the
32.4-kbp plasmid pE745-2. Additional antibiotic resist-
ance genes in the E. faecium E745 genome are the tri-
methoprim resistance gene dfrG [32], which is located
on plasmid pE745-6, and the chromosomally encoded
macrolide resistance gene msrC [33].
Transcriptome of E. faecium E745 during growth in rich
medium and in human serum
After confirming that serum can support the growth of
E. faecium E745, though at a lower growth rate than the
rich medium BHI (Additional file 2), the transcriptional
profile of E745 was determined by RNA-seq during ex-
ponential growth in BHI and in heat-inactivated human
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serum. A total of 99.9 million (15.6–17.6 million per
sample) 100 bp paired-end reads were successfully
aligned to the genome, allowing the quantification of
rare transcripts (Fig. 2). A total of 3217 transcription
units were identified, including 651 predicted multi-gene
operons, of which the largest contains 22 genes (Fig. 2a
and Additional file 3).
A comparative analysis of the E745 transcriptome dur-
ing growth in BHI and in human serum, showed that
860 genes exhibited significantly (q < 0.001 and a fold
change in expression of >2 or <0.5 between cultures
grown in BHI versus heat-inactivated serum) different
expression between these conditions (Additional file 4).
Among the genes with the highest difference in expres-
sion between growth in serum and in rich medium, we
identified a gene cluster with a role in purine biosyn-
thesis (Fig. 2b). In addition, we found a 58.4 kbp
prophage-like gene cluster that exhibited higher expres-
sion in E745 during growth in serum (Fig. 2c). Analysis
of this phage sequence against genome sequences depos-
ited at NCBI Genbank revealed that an essentially identi-
cal element (with 99% nucleotide identity) could be
identified in E. faecium ATCC 700221 but not in other
genome sequences of E. faecium or other bacteria.
To confirm the RNA-seq analysis, we independently
determined expression levels of eight genes during growth
in serum versus growth in BHI by qPCR (Additional
file 5). RNA-seq and qPCR data were highly concordant
(r2 = 0.98).
E. faecium E745 genes required for growth in human
serum
A mariner-based transposon mutant library was gener-
ated in E. faecium E745 and Tn-seq [24] was performed
on ten replicate transposon mutant libraries (after over-
night growth in BHI at 37 °C), resulting in an average of
15 million Tn-seq reads for each library. To analyze the
Tn-seq data, we divided the E745 genome in 25-nt win-
dows. Of a total of 110,601 25-nt windows, 49,984 (45%)
contained one or more sequence reads. No positional
bias was observed in the transposon insertion sites in
the chromosome and plasmids of E. faecium E745
(Additional file 6).
In order to identify genes that contribute to growth of
E. faecium E745 in human serum, we performed Tn-seq
on cultures of the E. faecium E745 transposon mutant
libraries upon growth in rich medium (BHI) and in hu-
man serum. The human serum was either used natively,
Fig. 1 Maximum likelihood phylogenetic tree of E. faecium. The phylogenetic tree was based on a core genome alignment of 1,545,750 positions
that was generated by ParSNP [61]. The tree includes the E. faecium E745 genome sequence generated in this study and the 72 E. faecium whole
genome sequences described in Lebreton et al. [4]. The tree was visualized and mid-point rooted using MEGA 7.0.26 [62]. The different E. faecium
clades are indicated. The position of E. faecium E745 in the phylogenetic tree is highlighted by an arrow
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or was heat-treated to inactivate the complement system
[34]. Minor differences were observed among condition-
ally essential genes between the experiments performed in
native human serum or heat-inactivated human serum
(Additional file 7) and the following results correspond to
the experiments obtained with heat-inactivated serum.
This condition was chosen because it may be a more re-
producible in vitro environment, particularly since the
interaction between the complement system and Gram-
positive bacteria remains to be fully elucidated [35, 36].
We identified 37 genes that significantly contributed to
growth of E745 in human serum (Fig. 3 and Additional
file 8): twenty-nine genes were located on the chromo-
some and eight genes were present on plasmids (six
genes on pE745–5, two genes on plasmid pE745–6).
The relatively large number of genes identified indicates
that growth of E. faecium in human serum is a multifac-
torial process. The genes that conferred the most pro-
nounced effect on growth of E. faecium in serum included
genes that are involved in carbohydrate uptake (manZ_3,
manY_2, ptsL), a putative transcriptional regulator (algB)
and genes involved in the biosynthesis of purine and pyr-
imidine nucleotides (guaB, purA, pyrF, pyrK_2, purD,
purH, purL, purQ, purC) (Fig. 3). Notably, the purD, purH,
and purL genes were found to exhibit higher expression
upon growth in human serum in the RNA-seq analysis
(Fig. 2). Nine genes were identified as negatively contribut-
ing to growth in serum, i.e. the transposon mutants in
these genes were significantly enriched upon growth in
serum. The effects of these mutations were relatively lim-
ited (Additional file 8), compared to the major effects
observed in the transposon mutants discussed above,
Fig. 2 Transcriptome analysis of E. faecium E745. Coverage plots of RNA-seq data aligning to chromosome and plasmid DNA are shown in panel
a. The y-axis of each track indicates reads coverage and is represented on a log scale, ranging from 0 to 10,000. The x-axis represents the genomic
location. Light blue (BHI) or orange (serum) tracks correspond to sequencing reads aligned to the plus strand of the replicon, and dark blue (BHI)
or dark red (serum) tracks correspond to sequencing reads aligned to the minus strand of the replicon. The grey track corresponds to multi-gene
operons. The green track corresponds to differentially expressed genes (BHI vs serum), with the height of the green bars indicative of differential
expression. In panels b and c, two serum-induced regions are shown, i.e. a gene cluster involved in nucleotide biosynthesis (panel b) and a pro-
phage (panel c). The RNA-seq experiments were performed using three biological replicates
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but it is notable that five (clsA_1, ddcP, ldtfm, mgs, and
lytA_2) of these genes have predicted roles in cell wall
and cytoplasmic membrane biosynthesis.
We developed a PCR-based method (Additional file 9)
to selectively isolate five transposon mutants (in the
purine metabolism genes purD and purH, the pyrimidine
metabolism genes pyrF and pyrK_2 and the phosphotrans-
ferase system (PTS) gene manY_2 from the transposon
library. Growth in rich medium of these transposon inser-
tion mutants was equal to the parental strain. However, all
mutants were significantly impaired in their growth in hu-
man serum (Fig. 4a), confirming the results of the Tn-seq
experiments.
E. faecium pyrK_2 and manY_2 contribute to intravenous
infection of zebrafish
Finally, we investigated whether the transposon insertion
mutants in the manY_2 and pyrK_2 genes were attenu-
ated in vivo (Fig. 4b). The mutants in these genes were
selected because they represent the mutants in nucleo-
tide and carbohydrate metabolism genes that were previ-
ously shown to contribute to the growth of E. faecium in
human serum. As a model for intravenous infection, we
used a recently described model in which E. faecium was
injected into the circulation of zebrafish embryos to
mimic systemic infections [37]. We showed that both
the manY_2 and the pyrK_2 mutant were significantly
less virulent than the parental strain. At 92 h post infec-
tion, survival of zebrafish embryos infected with the WT
strain was 53%, as compared to 88% and 83% for zebra-
fish embryos that were infected with the transposon in-
sertion mutants in manY_2 and pyrK_2, respectively.
Discussion
E. faecium can contaminate the skin and from there
colonize indwelling devices such as intravenous catheters,
or it can translocate from the gastrointestinal tract in im-
munosuppressed patients, leading to the development of
bacteremia and endocarditis. E. faecium infections are
often difficult to treat, due to the multi-drug resistant
character of the strains causing nosocomial infections
[3, 4]. However, the bloodstream poses challenges for
the proliferation and survival of E. faecium, including
a scarcity of nutrients.
In the present study, we sequenced the complete gen-
ome of a vancomycin-resistant E. faecium strain, and iden-
tified E. faecium genes that were essential for growth in
human serum. A total of 37 genes, including genes with
roles in carbohydrate uptake and nucleotide biosynthesis,
were found to be required for fitness of E. faecium E745
in serum. Previously, fitness determinants for growth in
human serum have been identified through large-scale
screening of mutant libraries in both a Gram-negative
(Escherichia coli) and a Gram-positive (Streptococcus
pyogenes) pathogen [38, 39]. Notably, these studies have
also identified the ability for de novo synthesis of purines
and pyrimidines as a crucial factor for growth in serum. In
addition, in diverse pathogenic bacteria (including Bur-
kholderia cepacia, Pasteurella multocida, Acinetobacter
baumannii, Salmonella enterica serovar Typhimurium,
Bacillus anthracis, and Streptococcus pneumoniae), nu-
cleotide biosynthesis contributes importantly to virulence
[40–45]. The ability to synthesize nucleotides de novo
thus appears to be an essential trait for the success of a
pathogen that spreads through the bloodstream [38]. The
Fig. 3 Tn-seq analysis to identify E. faecium genes required for growth in human serum. Bubbles represent genes, and bubble size corresponds
to the fold-changes (for visual reasons, a 100-fold change in transposon mutant abundance is set as a maximum) derived from the read-count ra-
tio of libraries grown in BHI to libraries grown in human serum. On the x-axis genes are shown in order of their genomic location and the
chromosome and plasmids are indicated. The outcome of statistical analysis of the Tn-seq data is indicated on the y-axis. Genes with a significant
change (q < 0.05) in fitness in serum versus BHI are grouped by function and are labelled with different colors, and the name or locus tag and
the change in abundance between the control condition and growth in serum is indicated next to the bubbles in parentheses. Negative values
indicate that mutants in these genes outgrow other mutants in serum, suggesting that these mutants, compared to the wild-type strain E. fae-
cium E745, have a higher fitness in serum
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data presented here indicate that de novo biosynthesis of
nucleotides is also required for E. faecium growth in
serum and virulence. The nucleotide biosynthesis pathway
of E. faecium may be a promising target for the develop-
ment of novel antimicrobials for the treatment of E.
faecium bloodstream infections. Indeed, compounds
that target guanine riboswitches, thereby inhibiting nu-
cleotide biosynthesis, have already shown their efficacy
in a Staphylococcus aureus infection model [46].
Three genes, ptsL, manY_2 and manZ_3, encoding
subunits of E. faecium PTSs were found to contribute to
growth in serum in our Tn-seq experiments. The ptsL
gene is predicted to encode an enzyme that confers a
phosphate group from phosphoenolpyruvate to Enzyme
I of PTS, while manY_2 and manZ_3 are predicted to
form the IIA and IIBC components of a permease system
that is homologous (64% and 69% amino acid identity,
respectively) to the PtnAB PTS permease of Lactococcus
lactis MG1363. PtnAB is one of the glucose uptake sys-
tems of L. lactis [47] and the E. faecium homolog may
have a similar function, which could explain its essential
role during growth in serum, as glucose is the only carbo-
hydrate that occurs in the free state in appreciable
amounts in serum [18].
It is notable that among the nine genes that exhibited
increased fitness upon inactivation by transposon inser-
tion, five genes are predicted to have a role in cell wall
or cytoplasmic membrane biosynthesis. The protein
encoded by ddcP was previously characterized as a low-
molecular-weight penicillin-binding protein with D-
alanyl-D-alanine carboxypeptidase activity [21], while
ldtfm acts as a peptidoglycan L,D transpeptidase [48].
The predicted α-monoglucosyldiacylglycerol synthase
gene mgs is orthologous (73% amino acid identity) to
bgsB in E. faecalis, which is required for the biosyn-
thesis of membrane glycolipids [49]. The clsA_1 gene is
predicted to be responsible for the synthesis of cardioli-
pin (bisphosphatidylglycerol) and its inactivation may
modulate the physical properties of the cytoplasmic
membrane [50]. Finally, lytA_2 is predicted to encode
an autolysin, which may be involved in the turnover of
peptidoglycan in the cell wall [51]. The transposon mu-
tants in these genes were not further characterized in
this study, but our findings suggest that non-essential
pathways of cell wall or cytoplasmic membrane remod-
elling may confer subtle fitness defects to E. faecium
when growing in a nutrient-poor environment, like
serum.
Our RNA-seq-based transcriptional profiling of E. fae-
cium E745 during mid-exponential growth in serum
showed pervasive changes in gene expression compared
to exponential growth in rich medium. The large num-
ber of differentially expressed genes may not all reflect
the different growth conditions (serum and BHI) per se,
but could also be influenced by the difference in growth
rate during mid-exponential growth in serum and BHI
(Additional file 2). The purine metabolism genes purL,
purH, purD, which were found to be required for growth
in serum in our Tn-seq experiments, were among those
that were significantly upregulated during growth in
serum compared to growth in rich medium. Notably, a
single prophage was expressed at higher levels during
growth in serum than in rich medium. The abundance
of prophage elements in the genome of E. faecium has
been noted before [4, 52]. Interestingly, in the related
A
B
Fig. 4 E. faecium transposon mutants with a growth defect in
human serum and an attenuated phenotype in a zebrafish infection
model. a Ratios of the viable counts of five mutants compared to
wild-type E. faecium before (blue bars) and after 24 h of growth in
human serum (red bars) or BHI (yellow bars). The viable counts of
wild-type E. faecium E745 were (3.52 ± 0.07) × 105/ml in the inocula,
(2.92 ± 0.14) × 108/ml after 24 h of growth in serum and (1.20 ± 0.20)
× 109/ml after 24 h of growth in BHI, respectively. Error bars
represent the standard deviation of the mean of three independent
experiments. Asterisks represent significant differences (***: p < 0.001,
****: p < 0.0001) as determined by a two-tailed Student’s t-test)
between the mutant strains and wild-type. b Kaplan-Meier survival
curves of zebrafish embryos upon infection with E. faecium. Infection
was initiated by the injection of 1.2 × 104 CFUs of the manY_2::Gm and
pyrK::Gm transposon mutants and the wild-type E. faecium E745 into
the circulation of zebrafish embryos 30 h post fertilisation. The
experiment was performed three times and the mutants were
significantly different (**: p < 0.01) from the wild-type in each
experiment as determined by the Log-rank (Mantel-Cox) test with
Bonferroni correction for multiple comparisons. This figure represents
the combined results of the three replicates for E. faecium E745 (n = 93
zebrafish embryos), manY_2::Gm (n = 92) and pyrK::Gm (n = 90)
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bacterium Enterococcus faecalis prophages encode
platelet-binding proteins [53] and may have a role in in-
testinal colonization [54]. The contribution of E. faecium
prophages to traits that are important for colonization
and infection may provide important insights into the
success of E. faecium as a nosocomial pathogen.
Conclusions
Our data indicate that nucleotide biosynthesis and carbo-
hydrate metabolism are critical metabolic pathways for
the proliferation and survival of E. faecium in the blood-
stream. The proteins encoded by the genes required for
growth in human serum that were identified in this study,
could serve as candidates for the development of novel
anti-infectives for the treatment of bloodstream-infections
by multi-drug resistant E. faecium.
Methods
Bacterial strains, plasmids, growth conditions, and
oligonucleotides
The vancomycin-resistant E. faecium strain E745 was used
throughout this study. This strain was isolated from a rec-
tal swab of a hospitalized patient, during routine surveil-
lance of a VRE outbreak in a Dutch hospital [27, 28].
Unless otherwise mentioned, E. faecium was grown in
brain heart infusion broth (BHI; Oxoid) at 37 °C. The E.
coli strains DH5α (Invitrogen) was grown in Luria-Bertani
(LB) medium. When necessary, antibiotics were used at
the following concentrations: chloramphenicol 4 μg ml−1
for E. faecium and 10 μg ml−1 for E. coli, and gentamicin
300 μg ml−1 for E. faecium and 25 μg ml−1 for E. coli. All
antibiotics were obtained from Sigma-Aldrich. Growth
was determined by measuring the optical density at
660 nm (OD660). The sequences of all oligonucleotides
used in this study are listed in Additional file 10.
Genome sequencing, assembly and bioinformatic analysis
E. faecium E745 was sequenced using a combination of
Illumina HiSeq 100 bp paired-end sequencing, long-read
sequencing using the Pacific Biosciences RS II SMRT
technology and the MinION system with R7 flowcell
chemistry (Oxford Nanopore Technologies). Corrected
PacBio reads were assembled using the Celera assembler
(version 8.1) [55] and assembled contigs were then cor-
rected by aligning Illumina reads using BWA (version
0.7.9a), with default parameters for index creation and the
BWA-MEM algorithm with the -M option for the align-
ment [56]. This approach resulted in 15 contigs, including
one contig covering the entire 2.77 Mbp chromosome.
After discarding contigs with low-coverage, the remaining
contigs constituted 5 circular plasmid sequences and 5
non-overlapping contigs. These 5 contigs were aligned
against the NCBI Genbank database and all were found to
be part of the E. faecium plasmid pMG1 [57]. Based on
this alignment the presumed order of contigs was deter-
mined and confirmed by gap-spanning PCRs and sequen-
cing of the products. A single gap between two contigs,
could not be closed by PCR. Thus, we assembled Illumina
reads together with MinION 2D reads using the SPAdes
assembler (version 3.0) [58], which produced a contig that
closed the gap, resulting in a complete assembly of this
plasmid. Sequence coverage of chromosomal and plasmid
sequences was determined with SAMtools (version 0.1.18)
using short read alignments to the assembly, which were
generated using BWA (version 0.7.9a). SAMtools was also
used to identify possible base-calling and assembly errors,
by aligning short reads to assembled contigs. A base was
corrected using the consensus of aligned reads [59]. The
corrected sequences were annotated using Prokka (version
1.10) [60]. A maximum likelihood phylogenetic tree based
on the core genome of E. faecium E745 and an additional
72 E. faecium strains representing the global diversity of
the species [4], was generated using ParSNP [61] with
settings -c (forcing inclusion of all genome sequences) and
-x (enabling recombination detection and filtering). The
resulting phylogenetic tree was visualized using MEGA
7.0.26 [62]. Antibiotic resistance genes in the assembled
genome sequence of E. faecium E745 were identified using
ResFinder [63]. The annotated genome of E. faecium E745
is available from NCBI Genbank database under accession
numbers CP014529 – CP014535.
RNA-seq
Approximately 3 × 107 cfu of E. faecium E745 were in-
oculated into 14 ml of BHI broth and heat-inactivated
serum, and grown at 37 °C until exponential phase.
Cultures were centrifuged at room temperature (15 s;
21.380 g), and pellets were flash frozen in liquid N2
prior to RNA extraction, which was performed as de-
scribed previously [21]. The ScriptSeq Complete Kit
(Bacteria) (Epicentre Biotechnologies, WI) was used for
rRNA removal and strand-specific library construction.
Briefly, rRNA was removed from 2.5 μg of total RNA.
To generate strand specific RNA-seq data, approxi-
mately 100 ng of rRNA-depleted RNA was fragmented
and reverse transcribed using random primers contain-
ing a 5′ tagging sequence, followed by 3′ end tagging
with a terminal-tagging oligo to yield di-tagged, single-
stranded cDNA. Following magnetic-bead based purifica-
tion, the di-tagged cDNA was amplified by PCR (15 cycles)
using ScriptSeq Index PCR Primers (Epicentre Biotech-
nologies, WI). Amplified RNA-seq libraries were purified
using AMPure XP System (Beckman Coulter) and se-
quenced by a 100 bp paired end reads sequencing run
using the Illumina HiSeq 2500 platform (University of
Edinburgh, United Kingdom). Data analysis was per-
formed using Rockhopper [64] using the default settings
for strand specific analysis.
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Validation of RNA-seq results by quantitative real-time
RT-PCR (qRT-PCR).
Total RNA isolated as described previously was used
to confirm the transcriptome analysis by qRT-PCR.
cDNA was synthesized as described above and qRT-
PCR on these cDNAs was performed using the Max-
ima SYBR Green/ROX qPCR Master Mix (Thermo
Scientific, Breda, The Netherlands) and a StepOnePlus
instrument (Life Technologies). The expression of
tufA was used as a housekeeping control. Ct values
were calculated using the StepOne analysis software
v2.2. Transcript levels, relative to tufA, of the assayed
genes were calculated using REST 2009 V2.0.13 (Qia-
gen, Venlo, the Netherlands). This experiment was
performed with three biological replicates.
Generation of mariner transposon mutant library in E.
faecium
To create a transposon mutant library in E. faecium
E745 suitable for Tn-seq, the mariner transposon cas-
sette (carrying a gentamicin resistance gene) in the
transposon delivery plasmid pZXL5 [21] was adapted
as follows. The transposon from pZXL5 was amplified
by PCR using the set of primers: pZXL5_MmeI_SacII_Fw
and pZXL5_MmeI_SacII_Rv. These primers introduced
MmeI restriction sites in the inverted repeats on both
sides of the transposon. The modified transposon delivery
vector, termed pGPA1, was generated by the digestion of
pZXL5 with SacII, followed by the insertion of the SacII-
digested mariner transposon that contained MmeI restric-
tion sites at its extreme ends. pGPA1 was electroporated
into E. faecium E745 and the transposon mutant library
was generated by selecting for gentamicin-resistant trans-
poson mutants as described previously [21].
Tn-seq analysis of conditionally essential genes in E.
faecium E745
The transposon mutant library created in E745 was
prepared for Tn-seq analysis, similar to previously de-
scribed procedures [65]. To identify genes that are es-
sential for the viability of E. faecium in BHI, we used
ten experimental replicates of the mutant library. Ali-
quots (20 μl) of the transposon mutant library, con-
taining approximately 107 cfu, were used to inoculate
20 ml BHI broth and grown overnight at 37 °C. Subse-
quently, 1 ml aliquots of the cultures were spun down
(15 s, 21.380 g) and used for the extraction of genomic
DNA (Wizard genomic DNA purification kit, Promega
Benelux). 2 μg of the extracted DNA was digested for
4 h at 37 °C using 10 U MmeI (New England Biolabs)
and immediately dephosphorylated with 1 U of calf
intestine alkaline phosphatase (Invitrogen) during
30 min at 50 °C. DNA was isolated using phenol-
chloroform extraction and subsequently precipitated
using ethanol. The DNA pellets were then dissolved in
20 μl water. The samples were barcoded and prepared
for Tn-seq sequencing as described previously [65].
The sequence reads from all ten experimental repli-
cates were mapped to the genome, and the mapped
read-counts were then tallied for the analysis of the
essentiality of the genes in the E. faecium E745 gen-
ome (further described below).
To identify genes that are required for growth in hu-
man serum, 20 μl aliquots of the frozen mutant library
in E745 were inoculated in BHI broth and grown over-
night as described above. Subsequently, bacterial cells
were washed with physiological saline solution. Approxi-
mately 3 × 107 cfu were inoculated into 14 ml BHI broth,
and approximately 3 × 106 cfu were inoculated into
14 ml human serum obtained from Sigma (Cat. No.
H4522; Sterile filtered type-AB human serum) or heat-
inactivated human serum (the same, after incubation for
30 min at 56 °C). The different inoculum-sized were
used in order for a similar number of divisions to occur
during the experiment. Cells were incubated at 37 °C for
24 h without shaking and then further processed for Tn-
seq [65]. This experiment was performed in triplicate.
Tn-seq samples were sequenced (50 nt, single-end) on
one lane of a Illumina Hiseq 2500 (Baseclear, Leiden, the
Netherlands and Sequencing facility University Medical
Center, Utrecht, The Netherlands), generating an average
of 15 million high quality reads per sample.
Tn-seq data analysis
Raw Illumina sequence reads from Illumina sequencing
were split, based on their barcode, using the Galaxy
platform [66], and 16-nucleotide fragments of each read
that corresponded to E745 sequences, were mapped to
the E745 genome using Bowtie 2 [67]. The results of
the alignment were sorted and counted by IGV [68]
using a 25-nucleotide window size and then summed
over the gene. Read mapping to the final 10% of a gene
were discarded as these insertions may not inactivate
gene function. Read counts per gene were then normal-
ized to the total number of reads that mapped to the
genome in each replicate, by calculating the normalized
read-count RPKM (Reads Per Kilobase per Million in-
put reads) via the following formula: RPKM = (number
of reads mapped to a gene × 106) / (total mapped input
reads in the sample x gene length in kbp). Statistical
analysis of the RPKM-values between the experimental
conditions was performed using Cyber-T [69]. Genes
were determined to be significantly contributing to
growth in human serum when the Benjamini-Hochberg
corrected P-value was <0.05 and the difference in
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abundance of the transposon mutant during growth in
BHI and serum was >2.
Isolation of mutants from the transposon mutant library
pool
To recover a targeted transposon mutant from the
complete mutant pool, a PCR-based screening strategy
was developed (Additional data file 9). 40 μl of the trans-
poson mutant library was inoculated into 40 ml of BHI
broth with gentamicin and grown overnight at 37 °C
with shaking (200 rpm). The overnight culture, contain-
ing approximately 109 cfu/ml, was then diluted to ap-
proximately 20 cfu/ml in 500 ml of BHI with gentamicin
and kept on ice. Subsequently, 200 μl aliquots were
transferred to wells of sterile 96 wells plates (n = 12,
Corning Inc.). After overnight incubation at 37 °C with-
out shaking, aliquots (15 μl) of each one of the 96 wells,
were further pooled into a single new 96 well plate, as
described in Additional file 9.
PCRs were performed on the final plate in which the
transposon mutants were pooled, to check for the pres-
ence of the Tn-mutants of interest, using the primer
ftp_tn_both_ends_MmeI, which is complementary to
the repeats flanking the transposon sequence, in com-
bination with a gene-specific primer. When a PCR was
found to be positive in one of the wells of this plate,
the location of the Tn-mutant was tracked backwards
to the wells containing approximately 4 independent
transposon mutants, by performing PCRs mapping the
presence of the transposon mutant in each step. Cells
from the final positive well were plated onto BHI with
gentamicin and colony PCR was performed to identify
the desired transposon mutant.
Growth of E. faecium E745 and individual mutants in
human serum
Wild-type E745 and the mutant strains were grown
overnight at 37 °C in BHI broth. Subsequently, bacterial
cells were washed with physiological saline and approxi-
mately 3 × 105 cfu were inoculated into 1.4 ml BHI broth
or heat-inactivated serum. Cells were grown in 1.5 ml
tubes (Eppendorf ) in triplicate for each condition and
incubated at 37 °C for 24 h without shaking. Bacterial
growth was determined by assessing viable counts, for
which the cultures were serially diluted using physio-
logical saline solution and plated onto BHI agar followed
by overnight incubation at 37 °C.
Intravenous infection of zebrafish embryos
London wild-type (LWT) inbred zebrafish embryos,
provided by the aquarium staff of The Bateson Center
(University of Sheffield), were used for infection experi-
ments. The parental E745 strain and its pyrK_2 and
manY_2 transposon mutants were grown in BHI broth
until they reached an optical density at 600 nm of ap-
proximately 0.5 and were then harvested by centrifuga-
tion (5500 g, 10 min). Bacteria were microinjected into
the circulation of dechorionated zebrafish embryos at
30 h post fertilization, as previously described [70].
Briefly, anesthetized embryos were embedded in 3% (w/
v) methylcellulose and injected individually with ap-
proximately 1.2 × 104 cfu using microcapillary pipettes.
For each strain, 29 to 32 infected embryos were ob-
served for survival up to 90 h post infection (hpi). This
experiment was performed in triplicate.
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Additional file 1: Genome sequence information for E. faecium E745.
(XLSX 10 kb)
Additional file 2: Growth of E. faecium E745 in BHI and serum. (PDF 962 kb)
Additional file 3: Operons identified by RNA-seq in E. faecium E745.
(XLSX 40 kb)
Additional file 4: E. faecium E745 genes that exhibited significant
(q < 0.001 and fold-change > 2) differential expression in human serum,
as determined by RNA-seq. (XLSX 70 kb)
Additional file 5: qRT-PCR validation of RNA-seq experiments. Correlation
of RNA-seq and qRT-PCR expression ratios for the seven genes with various
expression levels and genomic locations. The gene expression ratios
obtained from both qRT-PCR and RNA-seq were normalized by a
housekeeping control gene Efm745_00056 (tufA). The experiment was
performed with three biological replicates. (PDF 121 kb)
Additional file 6: Characterization of the E. faecium E745 transposon
mutant library, showing the number of reads that were mapped to the
E. faecium E745 chromosome and plasmids. The height of each peak
represents the read abundance at a specific insertion site. On the y-axis,
the number of mapped reads is shown on a log scale. (PDF 1427 kb)
Additional file 7: Tn-seq data: comparison of heat-inactivated and
native serum (XLSX 139 kb)
Additional file 8: E. faecium E745 genes that significantly (q < 0.05
and fold-change <−2 or >2) contribute to growth in human serum, as
identified by Tn-seq. (XLSX 13 kb)
Additional file 9: Isolation of mutants from the transposon mutant
library pool. (A) Schematic representation of the PCR reaction designed
to find a particular Tn-mutant within the transposon mutant library. This
PCR uses a combination of a gene-specific primer (blue arrow) and a
transposon specific primer primer (yellow arrow). Positive PCR products,
indicated by the green check marks, should occur when the transposon
(depicted as a yellow triangle) is inserted in the gene of interest
(depicted in blue). If the transposons inserted in adjacent genes or
intergenic regions, no PCR product can be amplified (red crosses). (B)
Schematic workflow to isolate Tn-mutants from the mutant library. The
transposon mutant library is split into 12 plates (A1 - A12) of 96 wells,
with each 200 μl well containing an average of 4 mutants. Plates were
incubated overnight (Step 2). Plate A1 was then pooled into the first
column of a new 96 well plate, denominated plate B1 (Step 3) and the
same was done for plates A2 to A12. Subsequently, plate B1 was pooled
again into the first column of a third plate, denominated C1 (Step 4). PCR
using the gene-specific primer and the transposon specific primer was
performed on the 8 wells of plate C1 (Step 5). A positive PCR was
suggestive of the presence of a particular transposon-mutant (depicted
as a red dot). The presence of the transposon mutant was then
confirmed by PCR in plate B1 (step 6) and the corresponding plate A
(step 7). Once a transposon-mutant was located to a particular well in
plate A, the well was plated on BHI plates containing gentamicin, and
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the colonies were screened for the presence of the transposon mutant
by PCR (step 8). (PDF 277 kb)
Additional file 10: Oligonucleotides used in this study. (XLSX 10 kb)
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